Publications by authors named "Laura Layos"

Claim this Profile
-
-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.
Alfredo Carrato, Roberto Pazo-Cid, Teresa Macarulla, Javier Gallego, Paula Jiménez-Fonseca, Laura Layos

NEJM Evid· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.
David Pesántez, Sanne Ten Hoorn, Isidro Machado, Xabier García-Albéniz, Nuria Rodríguez-Salas, Laura Layos

J Natl Cancer Inst· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy, big data and artificial intelligence as a new global clinical trial model in targeted therapy.
Albert Abad, Joana Vidal, Laura Layos, Cesar Morcillo, Izar Achaerandio

J Liq Biopsy· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies.
Anna Pous, Lucía Notario, Cinta Hierro, Laura Layos, Cristina Bugés

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?
Laura Layos, Eva Martínez-Balibrea, Vicenç Ruiz de Porras

Int J Mol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Advanced BRAF-Mutated Colorectal Cancer: Where We Are and Where We Are Going.
Chen Sun, Sofia España, Cristina Buges, Laura Layos, Cinta Hierro

Clin Colorectal Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.
Eudald Felip, Lucía Gutiérrez-Chamorro, Maica Gómez, Edurne Garcia-Vidal, Margarita Romeo, Laura Layos

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curcumin: A therapeutic strategy for colorectal cancer?
Vicenç Ruiz de Porras, Laura Layos, Eva Martínez-Balibrea

Semin Cancer Biol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.
Eric Van Cutsem, Margaret A Tempero, Darren Sigal, Do-Youn Oh, Nicola Fazio, Laura Layos

J Clin Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents.
Gabriela Antelo, Cinta Hierro, Juan Pablo Fernández, Eduardo Baena, Cristina Bugés, Laura Layos

Drugs Context· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial.
Carlos Fernández-Martos, Carles Pericay, Ferran Losa, Rocio García-Carbonero, Laura Layos

JAMA Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.
Vicenç Ruiz de Porras, Sara Bystrup, Sara Cabrero-de Las Heras, Eva Musulén, Luis Palomero, Laura Layos

Cancers (Basel)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistant mechanisms to BRAF inhibitors in melanoma.
José Luís Manzano, Laura Layos, Cristina Bugés, María de Los Llanos Gil, Laia Vila

Ann Transl Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.
Vicenç Ruiz de Porras, Sara Bystrup, Anna Martínez-Cardús, Raquel Pluvinet, Lauro Sumoy, Laura Layos

Sci Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Alba Ginés, Sara Bystrup, Vicenç Ruiz de Porras, Cristina Guardia, Eva Musulén, Laura Layos

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance.
Eva Martinez-Balibrea, Anna Martínez-Cardús, Alba Ginés, Vicenç Ruiz de Porras, Catia Moutinho, Laura Layos

Mol Cancer Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis